Democratic lawmakers, patient advocates and other stakeholders are cheering the Biden administration for extending subsidized Affordable Care Act coverage to DACA-recipients starting Nov. 1 in a long-awaited final rule out Friday (May 3).
FREE TRIAL Receive 30 days of no-obligation access. SIGN UP
The Senate Finance Committee released a draft bill that would create a new program within Medicare aimed at incentivizing hospitals, group purchasing organizations (GPOs) and other drug supply chain stakeholders to help create stable pricing for generic drug manufacturers by rewarding quality, reliability and long-term sustainable contracts.
Democratic lawmakers, patient advocates and other stakeholders are cheering the Biden administration for extending subsidized Affordable Care Act coverage to DACA-recipients starting Nov. 1 in a long-awaited final rule out Friday (May 3).
As a handful of key Senate Democrats and consumer advocates engage in a broader effort to get companies to disclose lobbying expenses, Public Citizen on Friday (May 3) blasted drug maker Eli Lilly for not making all its expenditures public in the run-up to its annual meeting next week where shareholders are slated to hold a vote demanding transparency.
The ranking Republican on the Senate health committee, Sen. Bill Cassidy (LA), is asking the Biden administration to provide more transparency on its gathering of scientific evidence surrounding the current outbreak of avian influenza, including information about the testing FDA is doing to measure the safety of the milk supply.
Health insurers can use an invalidated methodology to calculate the qualifying payment amounts (QPAs), or median in-network rates, that are integral to the No Surprises Act’s patient cost-sharing requirements -- and its independent dispute resolution (IDR) process -- for an additional six months, CMS announced this week.
Republicans raised concerns about any research collaboration between the United States and China at a House hearing this week, arguing work with scientists from China is inherently problematic, but a health researcher defended the work as necessary to guard against future pandemics.
Experts say the new center set up by FDA drug officials to boost clinical trial innovation has the potential to increase diverse enrollment in trials, and they hope the new initiative will end up encouraging decentralized trials, including greater use of wearable apps, and community-based approaches to recruitment.
A second Trump administration would do away from the White House Office of Pandemic Preparedness and Response Policy (OPPR), former president Donald Trump told Time in a wide-ranging interview during which he also said he would defer to states on abortion-related enforcement and water down protections for civil servants.
HOT TOPICS
A bipartisan group of senators have introduced legislation to establish a federally funded research prize for artificial intelligence advancements in health care, environmental protections, cybersecurity and national security, among other public interest goals. |
The Department of Defense (DOD) should be involved in the production of pharmaceuticals to help combat drug shortages that impact members of the military, the chair of the Senate Armed Services subcommittee on personnel suggested at a hearing, hinting that senators may pursue legislation that would allow DOD to make its own drugs. |
President Biden’s science advisors are recommending providing access to federal datasets to a broader range of researchers under an executive order for safe and secure artificial intelligence technologies. |
The chain drug store lobby told lawmakers on both sides of Capitol Hill Wednesday (May 1) that pharmacy benefit managers’ preexisting business practices exacerbated billing problems faced by pharmacies in the aftermath of the March Change Healthcare cyberattack that crippled the health care system and must be reformed. |
© 2002-2024. Inside Washington Publishers | Contact Us